Valeant says FDA denies approval to nail infection drug

Valeant says FDA denies approval to nail infection drug

Valeant said the FDA did not raise any questions regarding the efficacy or safety of the drug efinaconazole. The company said it was working on a timely response to the FDA. Onychomycosis causes nails to deform, discolor, thicken, become brittle and

2
Like
Save

Comments

Write a comment

*